Merck KGaA commits to continued partnership with Ugandan Government
September 5, 2017Manufacturing and Production, Medical Communications Merck, infertility, life sciences, pharma, pharmaceuticals, uganda
Merck KGaA has revealed plans to continue its commitment to a key partnership with the Ugandan Government via its non-profit …
Pfizer’s drug back on the market after proving safety
September 5, 2017Manufacturing and Production, Sales and Marketing Mylotarg, Pfizer, biotech, drugs, pharma, pharmaceutical
Back in 2000, Pfizer had a drug that was granted accelerated approval for the treatment of acute myeloid leukaemia (AML) …
Novartis celebrates success of Gilenya in paediatric multiple sclerosis
September 5, 2017Manufacturing and Production, Research and Development MS, Novartis, gilenya, health, multiple sclerosis, pharma, pharmaceuticals
Novartis has announced results of its Phase 3 study investigating the safety and efficacy of Gilenya (fingolimod) , finding that …
Merck KGaA to streamline business with $1bn healthcare sale
September 5, 2017Manufacturing and Production, Sales and Marketing GSK, Merck KGaA, biotech, drugs, pharma, pharmaceutical
Merck KGaA has revealed that it is looking to sell its consumer healthcare business, in order to refocus the business …
Asthma drugs reduce Parkinson’s risk by 50%, decade-long study finds
September 5, 2017Manufacturing and Production, Research and Development Parkinson's, Parkinson's disease, asthma, pharma, pharmaceuticals, salbutamol
A study from the Department of Global Public Health and Primary Care at the University of Bergen (UiB) in Norway …
12% of the UK have hearts ten years older than they are, Public Health England finds
September 4, 2017Research and Development, Sales and Marketing British Heart Foundation, Public Health England, cardiovascular disease, heart attack, heart health, stroke
New findings from Public Health England (PHE)’s Heart Age Test indicate that around 10% of men in the UK are …
Patently problematic? The impact of the Eli Lilly/Actavis intellectual property battle
September 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Eli Lilly, biotech, drugs, pemetrexed, pharma, pharmaceutical
The UK Supreme Court has sent shockwaves through the intellectual property world with its recent decision on Eli Lilly v …
NHS needs emergency £350 million to survive winter
September 4, 2017Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical
NHS Providers has stated that £350 million needs to be injected into the NHS to avoid the ‘humanitarian crisis’ that …
Takeda partners up to develop “next generation” CAR T solid tumour therapy
September 4, 2017Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, Noile-Immune, Takeda, pharma, pharmaceuticals
Takeda is set to partner with Noile-Immune Biotech in the development of a “next generation” chimeric antigen receptor T-cell (CAR …
Sanofi backs out of controversial Zika vaccine project
September 4, 2017Research and Development, Sales and Marketing Sanofi, US, Vaccine, Zika, biotech, drugs, pharma, pharmaceutical
Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …
Novartis CEO Jimenez announces retirement in 2018
September 4, 2017Sales and Marketing Novartis, Vasant Narasimhan, joe jimenez, pharma, pharmaceuticals
Novartis has announced that its Chief Executive, Joe Jimenez (pictured), is set to retire next year. In his place, Vasant …
Top Ten most popular articles on Pharmafile.com this week
September 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Trump, drugs, health, life sciences, medicine, pharma, pharmaceutical, top ten
This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …
R&D tax credits: A novel approach to supply chain funding
September 1, 2017Manufacturing and Production, Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical, tax credits
Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of HMRC’s R&D Consultative Committee, says R&D tax credits …
NICE rejects AstraZeneca’s breast cancer drug Faslodex
September 1, 2017Medical Communications, Sales and Marketing AstraZeneca, Cancer, Faslodex, breast cancer, life sciences, pharma, pharmaceutical
NICE has announced its decision to not recommend AstraZeneca’s breast cancer drug Faslodex (fulvestrant) in women who have oestrogen-receptor-positive, locally …
NHS pumps £100m into GP recruitment as numbers plummet
September 1, 2017Medical Communications GP, NHS, biotech, drugs, pharma, pharmaceutical
The NHS has been forced to offer £100 million to recruitment agencies in order to plug growing gaps in the …
FDA approves treatment to counter CAR-T side-effects
August 31, 2017Medical Communications, Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical
On the day that FDA announced the first CAR-T therapy would be given market authorisation, it also announced that a …
Has Trump’s power over pharma come to an end after Charlottesville?
August 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, J&J, JJ, Kenneth Frazier, MSD, President trump, Trump, life sciences, medicine, pharma, pharmaceuticals, president
In a shock move that was to have deeply resonant consequences, MSD Chairman and Chief Executive Officer Kenneth Frazier announced …
Lilly gets second shot at application for ‘blockbuster’ arthritis drug
August 31, 2017Sales and Marketing Eli Lilly, arthritis, baricitinib, biotech, drugs, pharma, pharmaceutical
Earlier this year, Eli Lilly was on the receiving end of one of the most surprising setbacks in recent times …
Teva scores expanded indication for Austedo in tardive dyskinesia
August 31, 2017Sales and Marketing FDA, Teva, medicine, pharma, pharmaceuticals
Following the FDA’s approval of Teva’s Austedo (deutetrabenazine) in the treatment of chorea associated with Huntington’s disease in April this …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
